logo

EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High HIV Incidence and Limited Resources

03 Oct, 2024
https://evawebsite.blob.core.windows.net/media/assets/Eva_announcment_10_gilead_for_web_1_0e96ace352.png

EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High HIV Incidence and Limited Resources

03 Oct, 2024